---
figid: PMC2912210__nihms216665f1
figlink: /pmc/articles/PMC2912210/figure/F1/
number: F1
caption: The classical MAP kinase pathway is activated in human tumors by several
  mechanisms including the binding of ligand to receptor tyrosine kinases (RTKs),
  mutational activation of an RTK, by loss of the tumor suppressor NF1, or by mutations
  in RAS, BRAF and MEK1. Phosphorylation and thus activation of ERK regulates transcription
  of target genes which promote cell cycle progression and tumor survival. The ERK
  pathway contains a classical feedback loop in which the expression of feedback elements
  such as SPRY and DUSP family proteins are regulated by the level of ERK activity.
  Loss of expression of SPRY and DUSP family members due to promoter methylation or
  deletion is thus permissive for persistently elevated pathway output. In the case
  of tumors with V600EBRAF expression, pathway output is enhanced by impaired upstream
  feedback regulation.
pmcid: PMC2912210
papertitle: 'Targeting the mitogen-activated protein kinase pathway: physiological
  feedback and drug response.'
reftext: Christine A. Pratilas, et al. Clin Cancer Res. ;16(13):3329-3334.
pmc_ranked_result_index: '120'
pathway_score: 0.9613626
filename: nihms216665f1.jpg
figtitle: 'Targeting the mitogen-activated protein kinase pathway: physiological feedback
  and drug response'
year: ''
organisms:
- Homo sapiens
ndex: 5ab4c8d0-dedc-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC2912210__nihms216665f1.html
  '@type': Dataset
  description: The classical MAP kinase pathway is activated in human tumors by several
    mechanisms including the binding of ligand to receptor tyrosine kinases (RTKs),
    mutational activation of an RTK, by loss of the tumor suppressor NF1, or by mutations
    in RAS, BRAF and MEK1. Phosphorylation and thus activation of ERK regulates transcription
    of target genes which promote cell cycle progression and tumor survival. The ERK
    pathway contains a classical feedback loop in which the expression of feedback
    elements such as SPRY and DUSP family proteins are regulated by the level of ERK
    activity. Loss of expression of SPRY and DUSP family members due to promoter methylation
    or deletion is thus permissive for persistently elevated pathway output. In the
    case of tumors with V600EBRAF expression, pathway output is enhanced by impaired
    upstream feedback regulation.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - BRAF
  - SPRY1
  - ERBB2
  - SPRY3
  - CCND1
  - RAF1
  - NRAS
  - RPS6KA2
  - FOS
  - HRAS
  - ARAF
  - MAP2K2
  - CCND2
  - DUSP5
  - SOS2
  - KRAS
  - NF1
  - PDGFRA
  - PDGFRB
  - RPS6KA3
  - DUSP3
  - SOS1
  - FGFRL1
  - GRB2
  - MAP2K1
  - DUSP6
  - EGFR
  - SPRY2
  - SPRY4
  - CCND3
  - DUSP1
  - DUSP2
  - RPS6KA1
  - FGFR3
  - DUSP4
  - FGFR4
  - MYC
  - MAPK3
  - FGFR1
  - MAPK1
  - ETS1
  - ETS2
  - FGFR2
  - ELK1
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
genes:
- word: B-RAF
  symbol: BRAF
  source: hgnc_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: SPRY
  symbol: SPRY
  source: bioentities_symbol
  hgnc_symbol: SPRY1
  entrez: '10252'
- word: HER2
  symbol: HER-2
  source: hgnc_alias_symbol
  hgnc_symbol: ERBB2
  entrez: '2064'
- word: SPRY
  symbol: SPRY
  source: bioentities_symbol
  hgnc_symbol: SPRY3
  entrez: '10251'
- word: CyclinD
  symbol: Cyclin_D
  source: bioentities_symbol
  hgnc_symbol: CCND1
  entrez: '595'
- word: C-RAF
  symbol: c-Raf
  source: hgnc_alias_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: RSK1/2/3
  symbol: RSK3
  source: hgnc_alias_symbol
  hgnc_symbol: RPS6KA2
  entrez: '6196'
- word: Fos
  symbol: FOS
  source: hgnc_symbol
  hgnc_symbol: FOS
  entrez: '2353'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: A-RAF
  symbol: ARAF
  source: hgnc_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: MEK1/2
  symbol: MEK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: CyclinD
  symbol: Cyclin_D
  source: bioentities_symbol
  hgnc_symbol: CCND2
  entrez: '894'
- word: DUSP
  symbol: DUSP
  source: bioentities_symbol
  hgnc_symbol: DUSP5
  entrez: '1847'
- word: SOS
  symbol: SOS
  source: bioentities_symbol
  hgnc_symbol: SOS2
  entrez: '6655'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: NF1
  symbol: NF1
  source: hgnc_symbol
  hgnc_symbol: NF1
  entrez: '4763'
- word: PDGFR
  symbol: PDGFR
  source: bioentities_symbol
  hgnc_symbol: PDGFRA
  entrez: '5156'
- word: PDGFR
  symbol: PDGFR
  source: bioentities_symbol
  hgnc_symbol: PDGFRB
  entrez: '5159'
- word: RSK1/2/3
  symbol: RSK2
  source: hgnc_alias_symbol
  hgnc_symbol: RPS6KA3
  entrez: '6197'
- word: DUSP
  symbol: DUSP
  source: bioentities_symbol
  hgnc_symbol: DUSP3
  entrez: '1845'
- word: SOS
  symbol: SOS
  source: bioentities_symbol
  hgnc_symbol: SOS1
  entrez: '6654'
- word: FGFR
  symbol: FGFR
  source: bioentities_symbol
  hgnc_symbol: FGFRL1
  entrez: '53834'
- word: GRB2
  symbol: GRB2
  source: hgnc_symbol
  hgnc_symbol: GRB2
  entrez: '2885'
- word: MEK1/2
  symbol: MEK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: DUSP
  symbol: DUSP
  source: bioentities_symbol
  hgnc_symbol: DUSP6
  entrez: '1848'
- word: EGFR
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: SPRY
  symbol: SPRY
  source: bioentities_symbol
  hgnc_symbol: SPRY2
  entrez: '10253'
- word: SPRY
  symbol: SPRY
  source: bioentities_symbol
  hgnc_symbol: SPRY4
  entrez: '81848'
- word: CyclinD
  symbol: Cyclin_D
  source: bioentities_symbol
  hgnc_symbol: CCND3
  entrez: '896'
- word: DUSP
  symbol: DUSP
  source: bioentities_symbol
  hgnc_symbol: DUSP1
  entrez: '1843'
- word: DUSP
  symbol: DUSP
  source: bioentities_symbol
  hgnc_symbol: DUSP2
  entrez: '1844'
- word: RSK1/2/3
  symbol: RSK1
  source: hgnc_alias_symbol
  hgnc_symbol: RPS6KA1
  entrez: '6195'
- word: FGFR
  symbol: FGFR
  source: bioentities_symbol
  hgnc_symbol: FGFR3
  entrez: '2261'
- word: DUSP
  symbol: DUSP
  source: bioentities_symbol
  hgnc_symbol: DUSP4
  entrez: '1846'
- word: FGFR
  symbol: FGFR
  source: bioentities_symbol
  hgnc_symbol: FGFR4
  entrez: '2264'
- word: Myc
  symbol: MYC
  source: hgnc_symbol
  hgnc_symbol: MYC
  entrez: '4609'
- word: ERK1/2
  symbol: ERK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: FGFR
  symbol: FGFR
  source: bioentities_symbol
  hgnc_symbol: FGFR1
  entrez: '2260'
- word: ERK1/2
  symbol: ERK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: Ets
  symbol: ETS
  source: bioentities_symbol
  hgnc_symbol: ETS1
  entrez: '2113'
- word: Ets
  symbol: ETS
  source: bioentities_symbol
  hgnc_symbol: ETS2
  entrez: '2114'
- word: FGFR
  symbol: FGFR
  source: bioentities_symbol
  hgnc_symbol: FGFR2
  entrez: '2263'
- word: Elk1
  symbol: ELK1
  source: hgnc_symbol
  hgnc_symbol: ELK1
  entrez: '2002'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
figid_alias: PMC2912210__F1
redirect_from: /figures/PMC2912210__F1
figtype: Figure
---
